QT
DSGN icon

Quantbot Technologies’s Design Therapeutics DSGN Stock Holding History

Quantbot Technologies’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,705
Closed -$6.87K – 1558
2024
Q1 		$6.87K Hold
1,705
– – ﹤0.01% 1472
2023
Q4 		$4.52K Sell
1,705
-2,200
-56% -$5.04K ﹤0.01% 1496
2023
Q3 		$9.22K Sell
3,905
-800
-17% -$3.73K ﹤0.01% 1416
2023
Q2 		$29.6K Sell
4,705
-6,148
-57% -$37.6K ﹤0.01% 1381
2023
Q1 		$62.6K Buy
+10,853
New +$81.2K ﹤0.01% 1208

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's DSGN Position: Q2 2024 in Review

Quantbot Technologies sold out of Design Therapeutics (DSGN) in Q2 2024, closing a stake of 1,705 shares — an estimated $6.87K sold.

Quantbot Technologies first reported a position in DSGN in Q1 2023 and held it in 5 quarters. The position peaked at $62.6K in Q1 2023. 95 funds tracked by Wall St. Rank hold DSGN as of Q2 2024.

  • Quantbot Technologies reported no remaining Design Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 1,705 Design Therapeutics shares in Q2 2024, an estimated $6.87K.
  • Quantbot Technologies first reported a position in Design Therapeutics in Q1 2023 and held it in 5 quarters.
  • Quantbot Technologies's Design Therapeutics position peaked at $62.6K in Q1 2023.
  • 95 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.